Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Clovis Oncology to Announce First Quarter 2019 Financial Results and Host Webcast Conference Call on May 7


Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its first quarter 2019 financial results on Tuesday, May 7, 2019, before the open of the U.S. financial markets. Clovis' senior management will host a conference call and live audio webcast at 8:30 a.m. ET to discuss the company's results in greater detail.

The conference call is being webcast and can be accessed from the Clovis Oncology website at www.clovisoncology.com. A replay of the webcast will be available for 30 days.

Conference Call Details

Clovis will hold a conference call to discuss first quarter 2019 results on Tuesday, May 7, at 8:30 a.m. ET. The conference call will be simultaneously webcast on the Company's web site at www.clovisoncology.com, and archived for future review. Dial-in numbers for the conference call are as follows: US participants 877.698.7048, International participants 647.689.5448, conference ID: 8567356.

About Clovis Oncology

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops, with partners, diagnostic tools intended to direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado; please visit www.clovisoncology.com for more information, including additional office locations in the U.S. and Europe.


These press releases may also interest you

at 13:30
The "Global Gift Card and Incentive Card Market Intelligence and Future Growth Dynamics (Databook) - Q1 2024 Update" report has been added to ResearchAndMarkets.com's offering. Global gift card industry is expected to grow by 7.9% on annual basis to...

at 13:18
Simmons Bank hosted a grand opening ceremony to celebrate the latest Pine Bluff financial center located at 1400 E. Harding Ave. Simmons Bank operates five full-service branches throughout Pine Bluff....

at 13:05
Regulatory News: MaaT Pharma (EURONEXT: MAAT ? the "Company"), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival of patients with cancer, today reported...

at 13:00
Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ("Nextdoor" or the...

at 13:00
The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Snowflake Inc. ("Snowflake" or the "Company") ....

at 13:00
Desjardins Investments Inc. ("DI"), as manager of the Desjardins Funds, announces changes to its mutual funds. These changes, described in detail below, consist of name changes to its range of SocieTerra Funds and Portfolios and two Wise ETF...



News published on and distributed by: